Last updated:
Brain Cancer: Cancer is considered a dangerous disease. It is also said that its treatment is quite expensive and expensive. Even after this, the success rate is very low.

AMU doctors have investigated the new medicine for brain cancer in 20 years of research
Aligarh: Researchers at the Interdisciplinery Brain Research Center of Aligarh Muslim University (AMU) located in Aligarh, Uttar Pradesh have discovered a new drug of brain cancer. The drug ‘ARSH-Q’, made for the treatment of brain cancer in the university, has also got a patent. Since 2005, research has been going on in the university. Now it will have a clinical trial on the rat. After this, a clinical trial will be done on humans. The team doing research at Aligarh Muslim University says that this drug will be very effective with other medicines.
On the ongoing research on brain cancer, the face of Dr. Mehndi Hayat Shahi, Member Dr. Mushir Ahmed, Arif Ali’s faces blossomed. This drug is going to prove to be a lifeline for those cancer patients, who are prone to brain cancer again. Most of the deaths occur due to brain cancer. The discovery of this drug is a ray of hope for more effective treatment options.
Researcher Dr. Mehndi Hayat Shahi, researcher at the Interdisciplinary Brain Research Center of Aligarh Muslim University, said that his aim was to find a drug that would be more effective than chemotherapy and temperature. “ARSH-Q” drug was discovered after much research and efforts. This drug has given extraordinary results in initial trials. “ARSH-Q” has shown extraordinary ability to prevent brain cancer cells. Especially those stem cells that are resistant to radiation and chemotherapy.
He said that since the year 2005, he has been researching this new medicine of brain cancer. Testing was started on the US by ordering brain cell (not human brain). Sonic hedgehog cell has served on the cell signaling pathway, which is important for the role of stem cells in brain cancer and other deadly diseases. After this “ARSH-Q” drug was discovered. Its initial tests have good results. Clinical trials will be done on humans after clinical trial on the rat.